Dafna Capital Management - aVenture Asset Manager Research
Location
Los Angeles, CA, US
Founded
1999
DAFNA Capital Management, based in Los Angeles, specializes in managing long/short portfolios of publicly traded biotechnology and medical device companies. Founded in 1999, the SEC-registered investment advisor focuses on capital preservation and strong annualized returns. Their expertise lies in identifying investment opportunities in the future of medicine.
The firm's portfolio includes notable companies such as Ardelyx, argenx, Minerva Neurosciences, Soligenix, and Syros Pharmaceuticals. DAFNA Capital Management's investment strategy combines unparalleled expertise, intellectual curiosity, and investment rigor to prudently manage their investors' wealth. Their approach involves funding innovative medical advancements while maintaining a focus on risk management.
Dafna Capital Management - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies5
Current Portfolio Count5
Top Investment Stages
Series A1 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of disclosed investments by stage.